| Literature DB >> 30030886 |
Xin Zhang1, Kai Qiu1, Liqi Wang1, Doudou Xu1, Jingdong Yin1.
Abstract
SCOPE: Protein restriction (PR) is beneficial for relieving metabolic disorders and aging-related diseases. However, extreme PR could result in malnutrition due to severe deficiency of essential amino acids. Therefore, the effect of moderate PR on insulin sensitivity is investigated. METHODS ANDEntities:
Keywords: gut-liver metabolism; insulin sensitivity; moderate protein restriction
Mesh:
Substances:
Year: 2018 PMID: 30030886 PMCID: PMC6646914 DOI: 10.1002/mnfr.201800637
Source DB: PubMed Journal: Mol Nutr Food Res ISSN: 1613-4125 Impact factor: 5.914
Figure 1Changes in plasma glucose, lipids, and insulin in response to moderate protein restriction. The plasma was collected from growing pigs in Experiment 1, in which growing pigs were offered to control (18% CP) or a moderate protein‐restricted diet (14% CP). Plasma levels of A) glucose, VLDL, LDL, HDL, total cholesterol (TC), triglyceride (TG), and B) insulin in the control (CON) and moderate protein restriction (PR) group. C) HOMA‐IR scores were used to reflect insulin resistance in the CON and moderate PR group. Data are expressed as mean ± SEM (n = 5–6). *Value significantly different from corresponding value in CON (p < 0.05). **Value significantly different from corresponding value in CON (p < 0.01).
Figure 2Modified IRS1/AKT signaling in the liver and skeletal muscle and repressed AMPK signaling in the liver in response to moderate protein restriction. Changes in p‐AKTSer473 and p‐IRS1Ser307 in the liver and skeletal muscle of growing pigs (Experiment 1) (A and C) and adult pigs (Experiment 2) (B and D). In addition, changes in p‐AMPKαThr172 in the liver of growing pigs (E) and adult pigs (F) were also observed upon moderate PR. Data are expressed as mean ± SEM (n = 5–6). *Value significantly different from corresponding value in the control group (CON, p < 0.05). **Value significantly different from corresponding value in CON (p < 0.01).
Figure 3Differentially expressed transcriptomic profile in the liver. A) Upregulated and downregulated KEGG pathways (Q < 0.05) respectively based on upregulated and downregulated differentially expressed transcripts. The horizontal line represents –log10 (Q‐value) for KEGG pathways. Red represents upregulated pathways, and green represents downregulated pathways upon moderate protein restriction (PR). B) Effects of moderate PR on insulin signaling related pathways based on all differentially expressed genes (DEGs), including insulin resistance, AMPK signaling pathway, insulin signaling pathway and PI3K‐AKT signaling pathway. The color of the columns represents gene expression status (red means genes upregulated upon moderate PR, green means downregulated upon moderate PR). C) Transcriptional regulatory network of DEGs in insulin signaling related pathways. Triangles represent KEGG pathways, and ellipses represent genes involved in KEGG pathways. The color of the ellipses represents gene expression status (red means genes upregulated upon moderate PR, green means downregulated in PR). Networks were visualized by Cytoscape (v3.5.1).
Different metabolites in the portal venous plasma from growing pigsa in response to moderate protein restriction
| Metabolites | Formula | Theoretical exact | Mean measured | Retention Time (min) | Fold change | Time (h) | Related pathway |
|---|---|---|---|---|---|---|---|
| Gly‐Gly‐Asp‐His | C14H20N6O7 | 385.1466 | 385.1461 | 3.02 | 1.74 | –0.5 | Protein metabolism |
| Indolelactic acid | C11H11NO3 | 206.0812 | 206.0809 | 2.58 | 0.30 | –0.5 | Tryptophan metabolism |
| Arg‐Val‐Ile‐Lys | C23H46N8O5 | 515.3664 | 515.3663 | 5.64 | 0.50 | –0.5 | Protein metabolism |
| Sphingosine‐1‐phosphate | C18H38NO5P | 380.2560 | 380.2552 | 4.72 | 0.51 | –0.5 | Sphingolipid signaling pathway |
| Linolenic Acid | C18H30O2 | 279.2319 | 279.2312 | 8.28 | 0.56 | –0.5 | Biosynthesis of unsaturated fatty acids |
|
| C5H11NO2S | 150.0583 | 150.0582 | 1.15 | 2.07 | 0.5 | Protein digestion and absorption |
| Stearoylethanolamide | C20H41NO2 | 328.3210 | 328.3203 | 9.91 | 1.80 | 0.5 | Downregulation the expression of SCD‐1 |
| Leucyl‐leucyl‐norleucine | C18H35N3O4 | 358.2700 | 358.2706 | 9.16 | 1.58 | 0.5 | Protein digestion or catabolism |
| Pantothenic Acid | C9H17NO5 | 220.1179 | 220.1175 | 1.58 | 1.53 | 0.5 | Metabolism and synthesis of carbohydrate, protein, and fat |
| 12‐oxo‐octadecanoic acid | C18H34O3 | 299.2581 | 299.2575 | 7.20 | 0.45 | 0.5 | Fatty acid biosynthesis |
| Deoxyuridine triphosphate (dUTP) | C9H15N2O14P3 | 468.9809 | 468.9824 | 0.77 | 1.68 | 1.5 | Pyrimidine metabolism |
|
| C6H11NO2 | 130.0863 | 130.0864 | 0.87 | 1.53 | 1.5 | Protein synthesis, amino acid biosynthesis |
| (4E,8E,10E‐d18:3)sphingosine | C18H33NO2 | 296.2584 | 296.2576 | 5.58 | 0.51 | 1.5 | Sphingolipid signaling pathway |
| 3‐Ketosphingosine | C18H35NO2 | 298.2741 | 298.2733 | 6.58 | 0.54 | 1.5 | Sphingolipid metabolism |
| 12‐Oxo‐octadecanoic acid | C18H34O3 | 299.2581 | 299.2574 | 7.21 | 0.55 | 1.5 | Fatty acid biosynthesis |
| Ser‐Glu‐Phe‐Ala | C20H28N4O8 | 453.1980 | 453.1987 | 3.38 | 0.61 | 1.5 | Protein metabolism |
| Cortisol | C21H30O5 | 363.2166 | 363.2157 | 3.04 | 0.48 | 7.5 | Steroid hormone biosynthesis |
| Pro‐Asp‐Ile | C15H25N3O6 | 344.1816 | 344.1810 | 2.21 | 0.55 | 7.5 | Protein metabolism |
Pigs from Experiment 3
Fold change, which was based on the normalized data, was calculated by a specific metabolite upon moderate protein restriction divided by that of control
CON, control group; PR, protein restriction
Time was the point that blood samples were obtained from the portal vein before or after feeding. A negative number indicated that blood samples were obtained before feeding, whereas the opposite was indicated by a positive number.
Figure 4Bioinformatics of differentially expressed proteins identified in the jejunal mucosa (Experiment 1). A) Cluster of KEGG pathways of all differentially expressed proteins (DEPs). The vertical line represents –log10 (p‐value) for KEGG pathways. B) Effect of moderate protein restriction (PR) on DEPs within each pathway category based on the KEGG analysis. C,D) DEPs related to metabolism were clustered on the heatmap by the normalized expression abundance (C) and networks were visualized by Cytoscape (v3.5.1) (D). FC, fold‐change; CON, control group.
Changed metabolism pathways and relevant differentially expressed proteins in the jejunal mucosa of growing pigsa in response to moderate protein restriction
| UniProtKB accession number | Protein name | Gene name | Fold change (PR/CON |
|---|---|---|---|
| Protein digestion and absorption | |||
| I3LUR7_PIG | Collagen alpha‐3(VI) chain | COL6A3 | 2.53 |
| AT1B1_PIG | Sodium/potassium‐transporting ATPase subunit beta‐1 | ATP1B1 | 2.44 |
| I7HD36_PIG | Sodium/potassium‐transporting ATPase subunit alpha‐1 | ATP1A1 | 2.37 |
| DPP4_PIG | Dipeptidyl peptidase 4 | DPP4 | 2.25 |
| CBPA1_PIG | Carboxypeptidase A1 | CPA1 | 1.92 |
| I3LS72_PIG | Collagen alpha‐1(VI) chain | COL6A1 | 1.90 |
| XPP2_PIG | Xaa‐Pro aminopeptidase 2 | XPNPEP2 | 1.67 |
| F1SHC8_PIG | Carboxypeptidase O | CPO | 1.64 |
| F1SFA7_PIG | Collagen alpha‐2(I) chain (Alpha‐2 type I collagen) | COL1A2 | 1.61 |
| K7GT00_PIG | COL14A1 protein (Collagen alpha‐1(XIV) chain) | COL14A1 | 1.56 |
| I3LB80_PIG | SLC3A2 protein | SLC3A2 | 0.65 |
| Carbohydrate digestion and absorption | |||
| F1RLV1_PIG | Sodium/glucose cotransporter 1 | SLC5A1 | 5.11 |
| I3LAV8_PIG | Alpha‐amylase | AMY2 | 3.18 |
| I3LMK2_PIG | Trefoil factor 2 | TFF2 | 2.90 |
| AT1B1_PIG | Sodium/potassium‐transporting ATPase subunit beta‐1 | ATP1B1 | 2.44 |
| I7HD36_PIG | Sodium/potassium‐transporting ATPase subunit alpha‐1 | ATP1A1 | 2.37 |
| SC5A4_PIG | Low affinity sodium‐glucose cotransporter | SLC5A4 | 1.74 |
| I3L7V1_PIG | Lactase | LCT | 0.58 |
| Citrate cycle (TCA cycle) | |||
| C560_PIG | Succinate dehydrogenase cytochrome b560 subunit, mitochondrial | SDHC | 2.31 |
| SDHA_PIG | Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial | SDHA | 2.10 |
| I3LP41_PIG | Malate dehydrogenase | MDH2 | 2.00 |
| IDHP_PIG | Isocitrate dehydrogenase [NADP], mitochondrial (Fragment) | IDH2 | 1.83 |
| F1S297_PIG | Isocitrate dehydrogenase [NAD] subunit, mitochondrial | IDH3G | 1.78 |
| F1SMA9_PIG | Succinate dehydrogenase [ubiquinone] cytochrome b small subunit | SDHD | 1.54 |
| SUCA_PIG | Succinyl‐CoA ligase [ADP/GDP‐forming] subunit alpha, mitochondrial | SUCLG1 | 0.62 |
| Oxidative phosphorylation | |||
| B5KN74_PIG | Cytochrome c oxidase subunit 1(Complex 4) | COX1 | 5.35 |
| F1S3W0_PIG | Cytochrome b‐c1 complex subunit 6 (Complex 3) | UCR6 | 2.62 |
| Q2NNM9_PIG | ATP synthase protein 8(Complex 5) | ATP8 | 2.42 |
| C560_PIG | Succinate dehydrogenase cytochrome b560 subunit, mitochondrial | SDHC | 2.31 |
| F1SCH1_PIG | NADH dehydrogenase 1 beta subcomplex subunit 7 | NDUFB7 | 2.28 |
| SDHA_PIG | Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial | SDHA | 2.10 |
| Q9G7R9_PIG | NADH‐ubiquinone oxidoreductase chain 3 (Complex 1) | NADH3 | 1.93 |
| I3LER5_PIG | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | COX4I1 | 1.70 |
| F1SMA9_PIG | Succinate dehydrogenase [ubiquinone] cytochrome b small subunit,mitochondrial | SDHD | 1.54 |
| F1SAB6_PIG | Acyl carrier protein (Complex 1) | NDUFAB1 | 1.51 |
| F1RPD4_PIG | Uncharacterized protein | LOC100620271 | 0.46 |
| I3LK43_PIG | NADH: ubiquinone oxidoreductase core subunit S7 | NDUFS7 | 0.60 |
| F1RNZ1_PIG | Cytochrome b‐c1 complex subunit Rieske, mitochondrial(Complex 3) | UQCRFS1 | 0.62 |
| F1SA40_PIG | ATPase H+ transporting V1 subunit D | ATP6V1D | 0.63 |
| F1SAK6_PIG | ATP synthase, H+ transporting, mitochondrial F0 complex, subunit G | ATP5L | 0.65 |
| Glutathione metabolism | |||
| MGST1_PIG | Microsomal glutathione S‐transferase 1 | MGST1 | 2.81 |
| F1RX66_PIG | Glutathione‐disulfide reductase | GSR | 2.28 |
| Q09HS4_PIG | Glutathione peroxidase | GPX2 | 2.16 |
| F1SK03_PIG | Aminopeptidase N | ANPEP | 1.81 |
| Q29057_PIG | Glutathione S‐transferase A2 | GSTA2 | 0.33 |
| Q000H9_PIG | Glutathione S‐transferase mu 2 | GSTM2 | 0.42 |
| F1S4 × 9_PIG | Glutathione synthetase | GSS | 0.61 |
| PPAR signaling pathway | |||
| F1RR40_PIG | Gastrotropin (Fragment) | FABP6 | 24.53 |
| Q2EN74_PIG | Epidermal fatty acid‐binding protein | FABP5 | 4.34 |
| F1SKG5_PIG | Glycerol kinase 5 | GK5 | 0.32 |
| APOC3_PIG | Apolipoprotein C‐III | APOC3 | 0.51 |
| CYB5_PIG | Cytochrome b5 | CYB5A | 0.57 |
| I3LCL6_PIG | Acyl‐CoA synthetase 5 | ACSL5 | 0.61 |
| FABPL_PIG | Fatty acid‐binding protein, liver | FABP1 | 0.63 |
| D5LIE7_PIG | Mitochondrial carnitine palmitoyltransferase II | CPT2 | 0.63 |
| F1S393_PIG | Cytochrome b5 type B | CYB5B | 0.64 |
Growing pigs from Experiment 1
CON, control group; PR, protein restriction.